STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Electromed, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Electromed, Inc. (ELMD) Form 144 reports a proposed sale of 65,714 shares of common stock via BTIG, LLC on the NYSE American with an aggregate market value of $1,554,136.10. The shares were acquired in the open market on 06/01/2021 and paid for in cash. The filing lists 8,349,176 shares outstanding for the class and shows no securities sold in the past three months. The proposed sale is scheduled for 09/10/2025. The filer affirms there is no undisclosed material adverse information.

Positive
  • Regulatory compliance: Filing clearly discloses the proposed sale and required acquisition/payment details under Rule 144
  • Transaction provenance: Shares were acquired in the open market and paid in cash, reducing concerns about non-cash consideration
  • Attestation provided: Filer represents no known undisclosed material adverse information
Negative
  • None.

Insights

TL;DR: Insider or affiliated holder plans a modest open-market sale of 65,714 shares worth $1.55M; compliance disclosed properly.

The filing documents a planned open-market disposition executed through BTIG, LLC with clear acquisition and payment dates. The position represents a small percentage of the stated outstanding shares, suggesting limited immediate dilution or market impact. The absence of any sales in the prior three months reduces the likelihood of an ongoing accelerated sell program. This is a routine Form 144 disclosure consistent with regulatory requirements.

TL;DR: The notice is a standard disclosure; it confirms representation about lack of undisclosed material information.

The filer includes the customary attestation that no material nonpublic information is known and provides transaction provenance (open market acquisition, cash payment). The scheduled sale date and broker identification meet procedural expectations for Rule 144 notices. From a governance perspective, the form fulfils transparency obligations but does not provide role or insider status of the seller.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ELMD's Form 144 report?

It reports a proposed sale of 65,714 common shares via BTIG, LLC on 09/10/2025 with aggregate value $1,554,136.10.

When and how were the shares acquired according to the filing?

The shares were acquired on 06/01/2021 in the open market and paid for in cash.

How many shares outstanding does the filing list for ELMD common stock?

The filing lists 8,349,176 shares outstanding for the class.

Did the filer report any securities sold in the past three months?

No; the filing states Nothing to Report for securities sold during the past three months.

Through which broker will the sale be executed?

The sale is to be executed through BTIG, LLC located at 350 Bush Street, 9th Floor, San Francisco, CA.
Electromed

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Latest SEC Filings

ELMD Stock Data

201.45M
6.62M
21.3%
53.31%
3.37%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE